Agnes Rey-Giraud

Agnès Rey-Giraud is chairman and CEO of Acera Surgical, Inc., which she co-founded in 2013. Acera Surgical has engineered a new class of resorbable synthetic hybrid-scale fiber matrices designed to restore damaged tissue. The proven healing power of Acera’s surgical matrices provides relief to patients who suffer from surgical wounds, trauma, burns, and chronic wounds, among other indications. Rey-Giraud played an essential role in devising Acera’s initial strategy, recruiting the company’s first leadership team, and securing the financial backing to bring revolutionary concepts from the lab to the operating room.

She was previously an officer at Express Scripts (NASDAQ : ESRX), a Fortune 100 company, where she served in multiple executive roles of increasing responsibility, including executive vice president of product development, supply chain, corporate strategy, and president of international operations.

Rey-Giraud currently serves as a member of the board of directors at UpHealth and chairs the compensation committee chair. She also serves on the board of GoodRx (NASDAQ : GDRX), a role she has held since 2016. She has served on numerous boards of directors, including RxHub (now SureScripts), a healthcare technology services company, from its design and creation in 2000 to 2006. During this period, RxHub transformed from a business plan to a service and technology platform, facilitating the creation of communication standards and the adoption of electronic prescribing in the US which is now the common standard in the country.